**Core Concept**
Human papillomavirus (HPV) and Hepatitis B virus (HBV) are associated with an increased risk of various cancers. Vaccination against these viruses can prevent the development of these cancers.

**Why the Correct Answer is Right**
The HPV vaccine targets high-risk HPV types, such as HPV-16 and HPV-18, which are responsible for approximately 70% of cervical cancer cases. The HBV vaccine, on the other hand, protects against Hepatitis B infection, which is a major risk factor for hepatocellular carcinoma. Both vaccines work by inducing immune responses that prevent viral infection and subsequent cancer development.

**Why Each Wrong Option is Incorrect**
**Option A:** The MMR (Measles, Mumps, and Rubella) vaccine is primarily used to prevent measles, mumps, and rubella infections, not cancers. While measles is associated with an increased risk of complications in individuals with weakened immune systems, it is not directly linked to cancer development.

**Option B:** The Varicella vaccine protects against chickenpox, which is caused by the Varicella-zoster virus. While chickenpox can lead to complications in certain individuals, such as those with weakened immune systems, it is not directly associated with an increased risk of cancer.

**Option C:** The Influenza vaccine is used to prevent seasonal influenza infections. While influenza can lead to severe complications, such as pneumonia and respiratory failure, it is not directly linked to cancer development.

**Option D:** This option is blank, so we can't evaluate it.

**Clinical Pearl / High-Yield Fact**
The HPV vaccine is most effective when administered before exposure to high-risk HPV types, typically in adolescence. This highlights the importance of vaccinating adolescents to prevent cancer development later in life.

**Correct Answer: B. Hepatitis B vaccine.**